118 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34264023 | HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy. | 2022 Mar | 1 |
2 | 34856444 | Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. | 2022 Feb | 1 |
3 | 35327653 | The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study. | 2022 Mar 17 | 5 |
4 | 35464301 | All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. | 2022 Jun | 5 |
5 | 35468014 | Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress via modulation of Keap1/Nrf2 signaling pathway. | 2022 Feb | 2 |
6 | 35490795 | Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells. | 2022 Apr 29 | 6 |
7 | 35505963 | miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. | 2022 Jun 14 | 1 |
8 | 35580917 | Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling. | 2022 May 17 | 2 |
9 | 35626727 | Activation of MT1/MT2 to Protect Testes and Leydig Cells against Cisplatin-Induced Oxidative Stress through the SIRT1/Nrf2 Signaling Pathway. | 2022 May 19 | 1 |
10 | 33148531 | Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells. | 2021 Feb | 1 |
11 | 33219317 | UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2. | 2021 Jan | 1 |
12 | 33610575 | Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade. | 2021 May 1 | 1 |
13 | 33735393 | Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism. | 2021 Jul | 2 |
14 | 33771701 | Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance. | 2021 May | 1 |
15 | 34080212 | Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression. | 2021 Jul | 1 |
16 | 34098867 | Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. | 2021 Jun 7 | 3 |
17 | 34237431 | Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells. | 2021 Sep 10 | 1 |
18 | 34239803 | Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma. | 2021 | 2 |
19 | 34320371 | The developmental origin of cancers defines basic principles of cisplatin resistance. | 2021 Oct 28 | 1 |
20 | 34407971 | Recurrent Human Papillomavirus-Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation. | 2021 Nov 15 | 1 |
21 | 34673143 | Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. | 2021 Dec | 1 |
22 | 34786050 | Bladder cancer cells prevent cisplatin-induced oxidative stress by upregulating Nestin1 expression. | 2021 | 1 |
23 | 30787448 | Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human. | 2020 Apr | 1 |
24 | 31583720 | Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2. | 2020 Apr | 2 |
25 | 31791583 | MBNL1 regulates resistance of HeLa cells to cisplatin via Nrf2. | 2020 Feb 12 | 2 |
26 | 31897145 | Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway. | 2020 Jan | 6 |
27 | 31974389 | The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity. | 2020 Jan 23 | 1 |
28 | 31983246 | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling. | 2020 Nov | 2 |
29 | 32012470 | MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. | 2020 Mar | 4 |
30 | 32088177 | Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory. | 2020 May 5 | 2 |
31 | 32092292 | Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury. | 2020 May | 1 |
32 | 32102425 | Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin. | 2020 Feb 24 | 2 |
33 | 32206093 | Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer. | 2020 | 1 |
34 | 32394538 | Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum-based chemotherapy in non-small cell lung cancer. | 2020 Jul | 3 |
35 | 32428544 | Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production. | 2020 Oct 1 | 7 |
36 | 32574971 | The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis. | 2020 Sep | 1 |
37 | 32800561 | Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. | 2020 Oct 20 | 1 |
38 | 32814771 | Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation. | 2020 Aug 20 | 2 |
39 | 32817372 | GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. | 2020 Aug 18 | 1 |
40 | 32927432 | Metformin suppresses Nrf2-mediated chemoresistance in hepatocellular carcinoma cells by increasing glycolysis. | 2020 Sep 14 | 1 |
41 | 32945421 | Panax notoginseng Saponins protect auditory cells against cisplatin‑induced ototoxicity by inducing the AKT/Nrf2 signaling‑mediated redox pathway. | 2020 Oct | 2 |
42 | 33041661 | Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway. | 2020 | 1 |
43 | 33066634 | Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells. | 2020 Oct 14 | 4 |
44 | 33232319 | LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1. | 2020 | 3 |
45 | 33290263 | Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells. | 2020 Dec 3 | 6 |
46 | 33294122 | The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer. | 2020 | 1 |
47 | 33489797 | Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2. | 2020 Dec | 2 |
48 | 30030687 | NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis. | 2019 Mar | 5 |
49 | 30668336 | Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression. | 2019 Mar 15 | 4 |
50 | 30811078 | The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. | 2019 Nov | 3 |